BRIEF published on 07/08/2025 at 22:15, 11 months 13 days ago GENFIT annonce son contrat de liquidité semestriel avec le Crédit Industriel et Commercial Biopharmaceutique Crédit Industriel Maladies Du Foie Liquidité De GENFIT Négociations 2025
PRESS RELEASE published on 07/08/2025 at 22:10, 11 months 13 days ago Genfit: Half-Year Report of Liquidity Contract with Crédit Industriel et Commercial GENFIT announces half-year report of liquidity contract with Crédit Industriel et Commercial, detailing trading activities and resources as of June 30, 2025 Liquidity Contract Financial Report Crédit Industriel Et Commercial Trading Activities GENFIT
PRESS RELEASE published on 07/08/2025 at 22:10, 11 months 13 days ago Genfit : Bilan semestriel du contrat de liquidité contracté avec le Crédit Industriel et Commercial GENFIT annonce le bilan semestriel de son contrat de liquidité avec le Crédit Industriel et Commercial, incluant les transactions et moyens de liquidité au 30 juin 2025 Contrat De Liquidité Bilan Semestriel Transactions Crédit Industriel Et Commercial GENFIT
BRIEF published on 06/17/2025 at 20:35, 1 year ago L'Assemblée Générale de GENFIT approuve les résolutions du Conseil d'Administration Resolutions Produits Biopharmaceutiques Assemblée Générale Des Actionnaires GENFIT Maladies Du Foie
BRIEF published on 06/17/2025 at 20:35, 1 year ago GENFIT's Shareholder Meeting Approves Board's Resolutions Biopharmaceuticals Resolutions Liver Diseases Shareholders Meeting GENFIT
PRESS RELEASE published on 06/17/2025 at 20:30, 1 year ago GENFIT: June 17, 2025 Combined Shareholders Meeting Results GENFIT announces approval of all resolutions at June 17, 2025 Combined Shareholders Meeting. Exception: resolution n°28 rejected. Quorum: 27.21% Resolutions Approval Quorum Shareholders Meeting GENFIT
PRESS RELEASE published on 06/17/2025 at 20:30, 1 year ago GENFIT : Résultats de l’Assemblée Générale Mixte du 17 juin 2025 GENFIT annonce les résultats de son Assemblée Générale Mixte du 17 juin 2025, approuvés avec un quorum de 27,21%, tout en dévoilant sa mission et activités dans le secteur biopharmaceutique Biopharmaceutique Assemblée Générale Mixte Maladies Rares GENFIT Foie
BRIEF published on 05/22/2025 at 22:15, 1 year ago GENFIT: First Quarter 2025 Financial Results Treasury Royalties GENFIT Iqirvo® Clinical Phase
BRIEF published on 05/22/2025 at 22:15, 1 year ago GENFIT : Résultats financiers du premier trimestre 2025 Trésorerie Royalties GENFIT Iqirvo® Phase Clinique
PRESS RELEASE published on 05/22/2025 at 22:10, 1 year ago GENFIT Reports First Quarter 2025 Financial Information GENFIT reports Q1 2025 financial information showing cash position growth and revenue increase. Details on Royalty Financing agreement, research efforts, and corporate governance update included Financial Information Revenue Cash Position GENFIT Q1 2025
Published on 06/22/2026 at 15:58, 1 hour 1 minute ago Metallic Minerals Closes Upsized C$10.3 Million Bought Deal LIFE Private Placement
Published on 06/22/2026 at 15:30, 1 hour 29 minutes ago NanoViricides Has Shipped NV-387 Oral Gummies Drug Product for Phase II Clinical Trial to DR Congo
Published on 06/22/2026 at 15:00, 1 hour 59 minutes ago Jaguar Health Announces Plan to Explore Strategic Alternatives Aligned with Targeted NDA Filing for Rare Disease Intestinal Failure Program
Published on 06/22/2026 at 14:01, 2 hours 58 minutes ago Worksport (NASDAQ:WKSP) Achieves 35% May Gross Margin, Lands Meyer Distribution, Targets $36M+ Revenue Run-Rate
Published on 06/22/2026 at 14:00, 2 hours 59 minutes ago Adcore Enters Strategic Partnership with TikTok as a Channel Sales Partner
Published on 06/22/2026 at 16:05, 54 minutes ago ACEMATE Tennis Robot S10 Gets $600 Prime Day Discount, with Bonus Gifts
Published on 06/22/2026 at 15:33, 1 hour 25 minutes ago Form 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc
Published on 06/22/2026 at 15:32, 1 hour 26 minutes ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc
Published on 06/22/2026 at 08:30, 8 hours 29 minutes ago Eiffage entre en négociation exclusive avec Atlas Arteria en vue d’acquérir la concession du tunnel de Warnow à Rostock, en Allemagne
Published on 06/22/2026 at 08:30, 8 hours 29 minutes ago Eiffage enters into exclusive negotiations with Atlas Arteria for the possible acquisition of the Warnow Tunnel concession in Rostock, Germany
Published on 06/19/2026 at 19:33, 2 days 21 hours ago Déclaration hebdomadaire d'opérations effectuées du 15 au 19 juin 2026
Published on 06/19/2026 at 19:33, 2 days 21 hours ago Disclosure of transactions in own shares from June 15 to June 19, 2026
